Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jaws Spitfire Acquisition Corporation was a special purpose acquisition company (SPAC) formed to facilitate a business combination; it completed a merger with Velo3D, a metal 3D printing technology company, in September 2021. After the merger, Velo3D became the operating company and began trading on the NYSE under the ticker VLD[2][1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jaws Spitfire Acquisition.